Evidence map›Paper›PMID 39844751›Full record

ArticleHaematologica2025

Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide study.

Barbara Gianesin, Frédéric B Piel, Khaled M Musallam, Susanna Barella, Maddalena Casale, Elena Cassinerio, Rosario Di Maggio, Antonia Gigante, Maria Rita Gamberini, Giovanna Graziadei and 15 more

Erratum issuedAbstract read
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Thalassaemia.Nature reviews. Disease primers · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Haematologica · 2025
    Article
4 · The record

Corrections and comments

  • Erratum issued
    2025
5 · Who and what money

Authors and funding

25 authors.

Barbara GianesinFor Anemia Foundation ETS, Genoa.
Frédéric B PielDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London.
Khaled M MusallamCenter for Research on Rare Blood Disorders (CR-RBD), Burjeel Medical City, Abu Dhabi, United Arab Emirates; Department of Public Health and Epidemiology, Khalifa University, Abu Dhabi, United Arab Emirates; Division of Hematology/Oncology, Department of Pediatrics, Weill Cornell Medicine, New York, NY.
Susanna BarellaSC Centro delle Microcitemie e Anemie Rare, ASL Cagliari, Cagliari.
Maddalena CasaleDepartment of Women, Child and General and Specialized Surgery, University Luigi Vanvitelli, Naples.
Elena CassinerioCentro Malattie Rare Internistiche, Medicina Generale, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan.
Rosario Di MaggioCampus of Haematology Franco and Piera Cutino, UOC Ematologia per le Malattie Rare Del Sangue e degli Organi Ematopoietici, AOOR Villa Sofia-V. Cervello, Palermo.
Antonia GiganteFor Anemia Foundation ETS, Genoa.
Maria Rita GamberiniSSD Day Hospital of Thalassemia and Hemoglobinopathies, Department of Specialized Medicine, Azienda Ospedaliero Universitaria S. Anna, Ferrara.
Giovanna GraziadeiCentro Malattie Rare Internistiche, Medicina Generale, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan.
Roberto LisiThalassemia Unit, ARNAS Garibaldi, Catania.
Filomena LongoSSD Day Hospital of Thalassemia and Hemoglobinopathies, Department of Specialized Medicine, Azienda Ospedaliero Universitaria S. Anna, Ferrara.
Aurelio MaggioCampus of Haematology Franco and Piera Cutino, UOC Ematologia per le Malattie Rare Del Sangue e degli Organi Ematopoietici, AOOR Villa Sofia-V. Cervello, Palermo.
Raffaella OrigaUniversita di Cagliari, SC Centro delle Microcitemie e Anemie Rare, ASL Cagliari, Cagliari.
Annamaria PasanisiCentro della Microcitemia A. Quarta, Hematology Unit, A. Perrino Hospital, Brindisi.
Silverio PerrottaDepartment of Women, Child and General and Specialized Surgery, University Luigi Vanvitelli, Naples.
Antonio Giulio PigaDepartment of Clinical and Biological Sciences, University of Turin, Turin.
Valeria Maria PintoHematology and Cellular Therapy, IRCCS Ospedale Policlinico San Martino, Genova.
Rosamaria RossoUOSD di Talassemia ed Emoglobinopatie, Azienda Ospedaliero Universitaria Policlinico San Marco, Catania.
Giacomo RobelloCentro della Microcitemia e Anemie Congenite e del Dismetabolismo del Ferro, Ospedale Galliera, Genoa.
Giovanna RussoPediatric Hematology/Oncology Unit, Universita di Catania, Catania.
Marco ZeccaFondazione IRCCS Policlinico San Matteo, Pavia.
Lucia De FranceschiDepartment of Engineering for Innovative Medicine, University of Verona, Verona, Italy; Azienda Ospedaliera Universitaria Integrata, Verona.
Gian Luca ForniFor Anemia Foundation ETS, Genoa, Italy; Hematology Unit, IRCCS Giannina Gaslini, Genoa. gianlucaforni14@gmail.com.
Italian Hemoglobinopathies National Survey Group.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39844751
PMCPMC12050947

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.